1. Epigenetically upregulating TROP2 and SLFN11 enhances therapeutic efficacy of TROP2 antibody drug conjugate sacitizumab govitecan
   Ming Zhao et al, 2023, npj Breast Cancer CrossRef
2. Decitabine combined with RDHAP regimen in relapsed/refractory diffuse large B cell lymphoma
   Xiaoshuang Kong et al, 2023, Cancer Medicine CrossRef